Total Funding
33
82
Total FundingGrant raised
Growth Score
-7 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
156637
EhmetDX is commercializing the latest advancements in medical device technology to address identifiable needs within the healthcare market.
Neal Clinthorne: Founder / Scientist- Michael Teicher: Founder and CEOPast Role: Xoran Technologies, Chief Executive Officer
About the Company
EhmetDX is commercializing the latest advancements in medical device technology to address identifiable needs within the healthcare market.
The company's patented technology allows the practitioner to deliver whole or partial breast irradiation while minimizing exposure to critical structures at risks such as lung, heart, and skin, and
lowering the whole-body dose to the patient. By offering these advantages, clinicians can apply novel approaches such as accelerated radiation treatment to reduce procedure time as well as allowing for advanced techniques such as stereotactic radiation therapy.
